Business Description
OliX Pharmaceuticals is a South Korean drug development company working on treatments for skin, eye, and lung conditions using a gene-silencing technology that targets specific molecules within the body. Founded in 2010 and based in Suwon-si, the company has built a range of experimental medicines addressing conditions such as scarring, hair loss, liver disease, and vision deterioration. OliX works alongside several partners, including Hansoh Pharmaceuticals and the University of Virginia, to advance its research and bring new therapies closer to patients.
